Book a demo

Company intelligence

endogene.bio

Building a legacy in female health

Biotechnology Research
Paris, France, FR
13 employees
Founded 2022
1 public signals

About endogene.bio

endogene.bio is building the biological data infrastructure for uterine health. 190 million women worldwide suffer from endometriosis, yet diagnosis still takes years and curative treatments remain unavailable. A fundamental challenge is the lack of high-quality human uterine biological data. By combining menstrual blood, advanced molecular profiling, and computational modeling, endogene.bio generates high-resolution biological data at scale, unlocking a previously inaccessible layer of human biology. Our work enables deeper understanding of disease mechanisms, patient stratification, biomarker discovery, and therapeutic development across uterine health. We collaborate with pharmaceutical companies, hospitals, clinics, and research organizations to accelerate the next generation of diagnostics and therapeutics in women's health.

Verified activity

Signals from endogene.bio

1 published signal

Find the companies already in motion.

Customize signals around your market, buyers, competitors, and investment thesis.

© 2026 SeedOpsCompany intelligence.

SeedOps.